Stock listing
AMGN34 Stock Price, News, Filings & Events — Amgen Inc.
Selected listing: AMGN34 · BMFBOVESPA · BRL · BR
This page tracks Amgen Inc.'s AMGN34:BMFBOVESPA listing on BMFBOVESPA in BRL for BR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AMGN34:BMFBOVESPA. AMGN34:BMFBOVESPA is the stock-level entry point for investors researching Amgen Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Amgen Inc. is a leading biotechnology company based in the United States, focused on developing innovative therapies for serious illnesses. With a market capitalization of approximately $197.7 billion, Amgen is recognized for its commitment to advancing science and improving patient outcomes. The company operates in a dynamic market, continually working to address unmet medical needs through its research and development efforts.
- Ticker
- AMGN34:BMFBOVESPA
- Asset type
- Stock
- Market cap
- $233.78B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BMFBOVESPA
- Currency
- BRL
Amgen Inc. AMGN34:BMFBOVESPA stock context
This page tracks Amgen Inc.'s AMGN34:BMFBOVESPA listing on BMFBOVESPA in BRL for BR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AMGN34:BMFBOVESPA. AMGN34:BMFBOVESPA is the stock-level entry point for investors researching Amgen Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Amgen Inc. is a leading biotechnology company based in the United States, focused on developing innovative therapies for serious illnesses. With a market capitalization of approximately $197.7 billion, Amgen is recognized for its commitment to advancing science and improving patient outcomes. The company operates in a dynamic market, continually working to address unmet medical needs through its research and development efforts.
Latest news from Amgen Inc.
TEZSPIRE® DEMONSTRATES POSITIVE PHASE 3 RESULTS IN EOSINOPHILIC ESOPHAGITIS ACROSS BOTH CO-PRIMARY AND ALL KEY SECONDARY ENDPOINTS
August 27, 2026
AMGEN TO OPEN NEW SCIENCE & INNOVATION CENTER IN GENOME VALLEY, HYDERABAD
August 12, 2026
AMGEN REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS
August 4, 2026
AMGEN ANNOUNCES 2026 THIRD QUARTER DIVIDEND
July 30, 2026
Amgen : POSITIVE CHMP OPINION SUPPORTS BROADER USE OF AMGEN'S REPATHA® BEFORE A FIRST HEART ATTACK OR STROKE
July 29, 2026
Amgen Inc. earnings calls
Amgen Inc. (AMGN) Q2 2026 Earnings Call
August 4, 2026 · Replay with transcript and chapters
Amgen Inc. (AMGN) Q1 2026 Earnings Call
April 30, 2026 · Replay with transcript and chapters
Amgen Inc. (AMGN) Q4 2025 Earnings Call
February 3, 2026 · Replay with transcript and chapters
Amgen Inc. (AMGN) Q3 2025 Earnings Call
November 4, 2025 · Replay with transcript and chapters
Amgen Inc. (AMGN) Q2 2025 Earnings Call
August 5, 2025 · Replay with transcript and chapters
Amgen Inc. (AMGN) Q1 2025 Earnings Call
May 1, 2025 · Replay with transcript and chapters
Research Amgen Inc.
Amgen Inc. investor report
Review AI stock analysis and investor report context for AMGN34:BMFBOVESPA.
Amgen Inc. company profile
View the public company page for Amgen Inc. on 6ix.
Amgen Inc. news
Read company news and market updates connected to Amgen Inc..
Amgen Inc. investor events
Find investor webinars, events, and replay context for Amgen Inc..
Alternate listings
AMGN:NASDAQ
US · USD
Alternate listing for Amgen Inc.; the primary context on this page is AMGN34:BMFBOVESPA.
AMG:GETTEX
DE · EUR
Alternate listing for Amgen Inc.; the primary context on this page is AMGN34:BMFBOVESPA.
AMGN:BCBA
AR · ARS
Alternate listing for Amgen Inc.; the primary context on this page is AMGN34:BMFBOVESPA.
AMG:XETR
DE · EUR
Alternate listing for Amgen Inc.; the primary context on this page is AMGN34:BMFBOVESPA.
AMGN06:SET
TH · THB
Alternate listing for Amgen Inc.; the primary context on this page is AMGN34:BMFBOVESPA.
AMG:TRADEGATE
DE · EUR
Alternate listing for Amgen Inc.; the primary context on this page is AMGN34:BMFBOVESPA.
AMGN:TSX
CA · CAD
Alternate listing for Amgen Inc.; the primary context on this page is AMGN34:BMFBOVESPA.
867900:LSX
DE · EUR
Alternate listing for Amgen Inc.; the primary context on this page is AMGN34:BMFBOVESPA.
AMGN:NEO
CA · CAD
Alternate listing for Amgen Inc.; the primary context on this page is AMGN34:BMFBOVESPA.
AMGND:BCBA
AR · USD
Alternate listing for Amgen Inc.; the primary context on this page is AMGN34:BMFBOVESPA.
AMGN:BMV
MX · MXN
Alternate listing for Amgen Inc.; the primary context on this page is AMGN34:BMFBOVESPA.
AMG:SWB
DE · EUR
Alternate listing for Amgen Inc.; the primary context on this page is AMGN34:BMFBOVESPA.